كويس الي خليتها
وشوف المعلومات الي عندي عن أصحاب الشركة واكيد عارفين شركتهم أكثر مننا
Pharmaceutical Product Development, Inc. options will trade on the January expiration cycle. Position and exercise limits have been set at 75,000 contracts. The issue has been allocated to lead market maker Gregg Webb of Susquehanna Investment Grou
(PPDI): Four Pharmaceutical Product Development Inc. insiders reported purchasing 111,500 shares of the company's common stock in May.
Chief Executive Fredric N. Eshelman purchased 100,000 shares between May 16 and Monday for prices from $23.97 to about $24.05 a share. Chairman Ernest Mario purchased 10,000 shares through a family limited partnership on May 16 for about $23.60 a share. President Fred B. Davenport Jr. purchased 1,000 shares May 12 for about $23.31 a share. Chief Financial Officer Linda Baddour purchased 500 shares May 7 for $24.37 a share. SALES
Chief Executive Fredric N. Eshelman purchased 100,000 shares between May 16 and Monday for prices from $23.97 to about $24.05 a share
MARIO ERNEST TITLE: Director TRANSACTION: Purchase 10,000 05/16/02 $23.60 OWNERSHIP: 761,768
DAVENPORT JR FRED B TITLE: President TRANSACTION: Purchase 1,000 05/12/02 $23.31 OWNERSHIP: 11,366
LINDA TITLE: Chief Financial Officer TRANSACTION: Purchase 500 05/07/02 $24.37 OWNERSHIP: 2,590
